← 返回

Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.

Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.

期刊: Interventional cardiology clinics 日期: 2026-10-01 PMID: 42648857 DOI: 10.1016/j.iccl.2026.05.002 浏览: 8
作者: Jabri A, Madanat L, Villablanca PA
A, J., L, M., & PA, V. (2026). Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.. Interventional cardiology clinics. https://doi.org/10.1016/j.iccl.2026.05.002
A J, L M, PA V. Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.. Interventional cardiology clinics. 2026; doi: 10.1016/j.iccl.2026.05.002
A J, L M, PA V. Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.[J]. Interventional cardiology clinics. 2026. DOI: 10.1016/j.iccl.2026.05.002.
@article{a2026,
  author = {Jabri A and Madanat L and Villablanca PA},
  title = {Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.},
  journal = {Interventional cardiology clinics},
  year = {2026},
  doi = {10.1016/j.iccl.2026.05.002},
  note = {PMID: 42648857},
}
TY  - JOUR
AU  - Jabri A
AU  - Madanat L
AU  - Villablanca PA
TI  - Balloon-Expandable Transcatheter Aortic Valve Replacement: A Comprehensive Review of Current Evidence and Clinical Outcomes.
T2  - Interventional cardiology clinics
PY  - 2026
DO  - 10.1016/j.iccl.2026.05.002
AN  - PMID:42648857
ER  - 

摘要

This article outlines the transformative impact of transcatheter aortic valve replacement (TAVR) since its first successful human use in 2002, redefining the management of severe aortic stenosis. Traditionally treated with surgical aortic valve replacement, many elderly patients with comorbidities were unsuitable for surgery. TAVR has emerged as a less invasive and widely adopted alternative, expanding from high-risk to low-risk populations with strong clinical outcomes. Its rapid global uptake and potential role in earlier intervention highlight its clinical significance. The article also introduces the 2 main valve platforms, balloon-expandable and self-expanding, focusing on their design and evolving applications.

AI 智能解读

相关文献

返回分类: 心血管 查看原文 (DOI)
已选择 0 篇文献